The FDA authorized Aurobindo Pharma to produce and market three doses of hypertension drug fosinopril sodium, a generic version of Bristol-Myers Squibb's Monopril.
Published in Brief:
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||